Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,100 DKK | +2.34% | +0.02% | -17.29% |
Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-17.29% | 5.44M | |
-2.21% | 104B | |
+1.90% | 97.42B | |
+1.22% | 22.2B | |
-17.94% | 21.23B | |
-11.00% | 18.33B | |
-42.33% | 16.35B | |
-18.46% | 15.06B | |
+5.24% | 13.98B | |
+27.20% | 11.66B |
- Stock Market
- Equities
- ORPHA Stock
- News Orphazyme A/S
- Orphazyme A/S : European ADRs Edge Higher in Wednesday Trading